Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06907875 FSHD — A First-in-human Study of EPI-321 in Facioscapulohumeral Muscula… |
EPI-321 | Myopathies | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Epicrispr Biotechnologies, Inc. | United States, Australia, New Zealand · David Geffen … | 2025-05-08 → 2032-04-30 | Ouvrir |
| NCT06733935 A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (… |
NKX019 | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Nkarta, Inc. | United States, Australia, Puerto Rico · Nkarta Invest… | 2024-11-04 → 2028-10 | Ouvrir |
| NCT07752264 A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotiz… |
Equecabtagene Autoleucel Injectio… | Myopathies | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | Nanjing IASO Biotechnology Co., L… | China · China-Japan Friendship Hospital, Beijing, Chi… | 2026-08-15 → 2043-08-15 | Ouvrir |
| NCT07052929 Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy… |
ASP2957 | Myopathies | Phase 1/2 | RECRUITING | En attente / non publié | Astellas Gene Therapies | United States, Canada · Boston Children's Hospital, B… | 2025-12-15 → 2027-10-31 | Ouvrir |
| NCT07089121 Descartes-08 for Children, Adolescents, and Young Adults With Autoimmun… |
Descartes-08 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Cartesian Therapeutics | United States · Cincinnati Children's Hospital Medica… | 2026-01-14 → 2028-12 | Ouvrir |
| NCT02472795 Clinical Study to Investigate the Biological Activity, Safety, Tolerabi… |
Cenerimod | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Viatris Innovation GmbH | United States, Belarus, Bulgaria, Georgia, Russia, Uk… | 2015-06-01 → 2017-02-28 | Ouvrir |
| NCT06947460 CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH |
CD19-BCMA CAR-T cells infusion | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Beijing GoBroad Hospital | China · 北京高博医院, Beijing, China | 2025-04-18 → 2026-07-31 | Ouvrir |
| NCT06032923 Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Bo… |
Double-blind Placebo Controlled S… | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | National Heart, Lung, and Blood I… | United States · National Institutes of Health Clinica… | 2024-03-13 → 2028-08-01 | Ouvrir |
| NCT07005297 Clinical Genetics Branch Eligibility Screening Survey |
Clinical Genetics Branch Eligibil… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Cancer Institute, Rockville,… | 2026-08-19 → 2036-01-01 | Ouvrir |
| NCT07629258 GW01-200-01 — A Phase I Trial of GW01-200 Tablets in Subjects With Adva… |
GW01-200 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Groovy Medicine (Hangzhou) Ltd. | China · Hebei Cancer Hospital of Chinese Academy of M… | 2026-07-17 → 2029-06 | Ouvrir |
| NCT07764497 HAIP-6192 — Hepatic Arterial Infusion Chemotherapy in Patients With Ino… |
Floxuridine (FUDR) | Cancer | Phase 2 | RECRUITING | En attente / non publié | Sunnybrook Health Sciences Centre | Canada · Sunnybrook Health Sciences Centre, Toronto, … | 2014-07 → 2036-12 | Ouvrir |
| NCT05650749 GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastati… |
GPC2 CAR T cells | Cancer | Phase 1 | ENROLLING_BY_INVITATION | En attente / non publié | Stephan Grupp MD PhD | United States · Children's Hospital of Philadelphia, … | 2023-05-23 → 2030-01-30 | Ouvrir |
| NCT07764432 CHOOSE — Communication and Hospice Online With Optimal Support and Enga… |
CHOOSE — Communication and Hospic… | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Washington University School of M… | United States · Washington University School of Medic… | 2027-02-01 → 2031-04-30 | Ouvrir |
| NCT06822543 TROPICAL-1 — A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Car… |
Pembrolizumab | Cancer | Phase 2 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Brazil · A.C. Camargo Cancer Center, São Paulo, Brazi… | 2025-09-12 → 2028-11-01 | Ouvrir |
| NCT07053020 A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral… |
Cytarabine | Cancer | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · The University of Texas M. D. Anderso… | 2027-12-01 → 2030-06-30 | Ouvrir |
| NCT05464823 Feasibility of Combined Genomics/Transcriptomics for Patients With Lymp… |
Feasibility of Combined Genomics/… | Cancer | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · M D Anderson Cancer Center, Houston, … | 2022-07-07 → 2027-05-12 | Ouvrir |
| NCT06806033 A Study to Evaluate the Optimization of the Cytokine Release Syndrome P… |
Obinutuzumab | Cancer | Phase 2 | RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Australia, Canada, France, Germany, It… | 2025-03-05 → 2029-03-30 | Ouvrir |
| NCT05083481 A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Eith… |
ASP1570 | Cancer | Phase 1 | TERMINATED | En attente / non publié | Astellas Pharma Global Developmen… | United States, China, France, Japan, Puerto Rico, Spa… | 2021-10-19 → 2026-05-11 | Ouvrir |
| NCT07764601 RM-MA-PD1 — R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lympho… |
Penpulimab | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | WEI XU | China · The First Affiliated Hospital of Nanjing Medi… | 2026-08 → 2029-08 | Ouvrir |
| NCT06490328 Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer |
DKF-MA102 | Cancer | Phase 3 | COMPLETED | En attente / non publié | Dongkook Pharmaceutical Co., Ltd. | South Korea · ASAN Medical Center, Seoul, South Korea… | 2024-05-30 → 2026-03-09 | Ouvrir |
| NCT07604766 RAINFOL-02 — An Extension Study to Assess the Efficacy of Rina-S Compar… |
Rina-S | Cancer | Phase 3 | RECRUITING | En attente / non publié | Genmab | China · Chongqing University Cancer Hospital - Chongq… | 2026-06-26 → 2028-12 | Ouvrir |
| NCT06667687 Study to Evaluate Adverse Events, Change in Disease Activity, and How I… |
ABBV-291 | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | AbbVie | United States, Australia, Israel, Japan, United Kingd… | 2025-01-16 → 2027-04 | Ouvrir |
| NCT06157801 Evaluation of Hereditary Cancer Educational Videos |
Evaluation of Hereditary Cancer E… | Cancer | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · MD Anderson Cancer Center, Houston, U… | 2024-04-05 → 2027-10-31 | Ouvrir |
| NCT07313332 ReHIIT_CON — Exploring Resistance Exercise Training Plus High-Intensity… |
ReHIIT_CON — Exploring Resistance… | Cancer | Non applicable | RECRUITING | En attente / non publié | University of Nottingham | United Kingdom · Medical School, University of Nottin… | 2026-01-01 → 2027-12-01 | Ouvrir |
| NCT07262567 Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRA… |
GFH375 | Cancer | Phase 3 | RECRUITING | En attente / non publié | Genfleet Therapeutics (Shanghai) … | China · Peking University Cancer Hospital & Institute… | 2025-12-04 → 2028-06 | Ouvrir |